Skip to Main Content

Paper Details

Phase I trial of panobinostat in children with diffuse intrinsic pontine glioma: A report from the Pediatric Brain Tumor Consortium (PBTC-047).
Neuro Oncol
8
2023
ALT, DIPG, DMG, Diffuse intrinsic pontine glioma, Diffuse midline glioma, Panobinostat, Pediatric Brain Tumor, Posterior reversible encephalopathy syndrome, childhood cancer, children, myelosuppression, nausea, neutropenia, panobinostat, patient, pontine glioma, thrombocytopenia
Author NameAffiliation
Michelle MonjeStanford University and Lucile Packard Children's Hospital
Tabitha CooneyDana Farber Cancer Institute/Boston Children's Hospital
Patricia BaxterTexas Children's Cancer Center
Lindsay KilburnChildren's National Hospital
Lindsay KilburnChildren's National Hospital
Nada JabadoResearch Institute of the McGill University Health Center
Nada JabadoResearch Institute of the McGill University Health Center
Maryam FouladiNationwide Children's Hospital
Jason Fangusaro
Katherine E WarrenDana Farber Cancer Institute/Boston Children's Hospital
Katherine E WarrenNational Cancer Institute
  • 1 - 11

Datasets

Release 1.2